Contacts for Patients and Clinical Trial Related Information
AstraZeneca Clinical Study Information Center
Call Center: 1-877-240-9479
All Adverse Events and Product Quality Complaints in the US should be reported to the AstraZeneca Information Center at: 1-800-236-9933
Early access to Acerta Pharma medicinal products
We recognize that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enroll in one of our clinical trials. In such circumstances, individual patients may be eligible for early access to an Acerta medicinal product. Acerta Pharma reviews requests following principles aligned with AstraZeneca.